Purchase Order 75D30122P14659
- Not listed
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $9,998.94 to Becton, Dickinson and Company (BD) for the procurement of BD Biosciences Accuri C6 Plus flow cytometers. The contract has an ultimate completion date of April 22, 2025. BD is a global medical technology company that provides a comprehensive range of products and services to federal agencies, including specialized equipment, instruments, and reagents for biomedical...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for annual repairs and maintenance of BD flow cytometers. The contract has a ceiling value of $17,834.96 and a period of performance through January 31, 2025. No set-aside designation was used. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
- This federal contract award, valued at $41,964.95, was issued by the Southeast Area of the U.S. government's civilian agencies to Becton, Dickinson and Company (BD), a global medical technology manufacturer, to deliver a C6 flow cytometer as described in a quote. The contract is a firm fixed-price delivery order with no set-aside designation, indicating BD's competitive position in the federal marketplace. BD is a large, for-profit organization with a strong track record of providing specialized...
- This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for maintenance services on three BD flow cytometry instruments. The contract has a period of performance from February 1, 2025, through January 31, 2026, with a ceiling value of $137,625.12. The contract does not utilize any set-aside designations. BD, a global medical technology manufacturer, is providing maintenance services for a FACSymphony...
- This is a firm fixed-price delivery order contract awarded by the Central Program Planning Coordination and Support, a civilian agency, to Becton, Dickinson and Company (BD) for flow cytometer maintenance services. The contract has a total ceiling value of $22,227.12 and a completion date of November 11, 2026. BD is a large, for-profit manufacturer of medical devices and instruments, including specialized flow cytometry equipment. The contract does not utilize a small business set-aside. BD...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Becton, Dickinson And Company (BD) for the procurement of a BD FACSARIA FUSION flow cytometer. The $392,789.62 firm fixed price contract has an April 30, 2017 completion date. BD is a global medical technology company that provides specialized instruments, reagents, and services to support biomedical research and clinical applications through its BD Biosciences...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a flow cytometry maintenance agreement. The contract has a ceiling value of $353,344.70 and a period of performance through November 29, 2024. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
- This $110,986.32 firm fixed-price purchase order contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Becton, Dickinson And Company (BD), a global medical technology company, to provide laboratory instruments. The contract does not have a set-aside designation. BD, through its BD Biosciences division, is a major supplier of products and services for laboratory and biomedical research applications, including flow cytometers, cell...
- This federal contract award is for preventative maintenance and repair services for FACSCANTO II flow cytometers. The contract was awarded to Becton, Dickinson and Company (BD), a major supplier of flow cytometry equipment, cell imaging technologies, and genomics solutions to federal agencies. The contract has a ceiling value of $87,586.20 and a term through September 13, 2028. This is a delivery order contract with a firm fixed-price pricing structure, awarded by the Food and Drug...
- This firm fixed-price contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) to provide a new flow cytometer system configured per the quote. The contract has a potential value of $772,218.37 and a completion date of February 9, 2023. The contract was awarded on September 18, 2019 and was not set aside for any specific business type. BD is a...
This federal contract award is for a service agreement with Becton, Dickinson and Company (BD) to provide BD flow cytometers. The contract, worth $94,554.12, was awarded by the Centers for Disease Control and Prevention (CDC) on July 21, 2022, and has a completion date of September 20, 2023. The contract is a firm fixed-price purchase order and does not have a set-aside designation. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. BD has a long history of supplying specialized equipment and consumables to various U.S. government agencies, including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense, to support their biomedical research and clinical programs. This contract with the CDC aligns with the agency's mission to provide critical public health services and research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $94.6k | 7/21/22 |